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ABSTRACT 
Clinical evidence suggested that biological behavior as well as response to treatment is 
different in OSCC arising from the different anatomical locations of the mouth and 
could be influenced by the activation or/and inactivation of different genes and 
pathways. Objective: Gene expression analysis of OSCC from different sites of the oral 
cavity was conducted to determine if there were significant differences in the expression 
pattern that could be associated with clinical observations. Materials and Methods: 
Formalin-fixed paraffin-embedded tissues from OSCC from cheek, gum, tongue and 
non-cancerous oral mucosal from the matching sites were used in microarray 
experiments (DASL, Illumina) to determine the gene expression patterns. Microarray 
data were analysed using Genespring to identify differentially expressed genes and 
these changes were validated using quantitative polymerase chain reaction and 
immunohistochemistry. The role of specific genes in driving OSCC were determined 
using cell lines genetically modified to exogenously express these genes. Results: This 
study demonstrated that FFPE tissues can be used for microarray experiments. 
Differentially expressed genes in OSCC were identified and their expressions were 
validated in independent samples. Principal Component Analysis demonstrated that 
different sites of OSCC have distinct gene expression profiles. Genes that were 
commonly altered in all sites and those that were distinct to a particular site were 
identified. Focusing on a gene FOLR1 that was found to be enriched in OSCC of the 
tongue, exogenous expression of this gene was shown to promote migration and 
invasion. Conclusion: This study suggests that the genetic progression of OSCC in the 
different sites is distinct, thus cautioning the generalization of OSCC when identifying 
biomarkers for diagnosis, prognosis and therapy. Furthermore, specific genes may 
confer different cancer traits that may explain the clinical differences seen in the 
different sites of OSCC. 
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ABSTRAK 
Bukti klinikal mencadangkan tingkah laku biologi serta respons kepada rawatan berbeza 
di kalangan OSCC dari lokasi berbeza di mulut. Ia berkemungkinan dipengaruhi oleh 
pengaktifan atau/dan penyahaktifan gen serta tapak jalan gen yang berbeza. Objektif: 
Analisis ekspresi gen OSCC dari lokasi berbeza di mulut dijalankan untuk menentukan 
jika ada perbezaan signifikan dalam pola ekpresi berkaitan dengan pemerhatian klinikal. 
Bahan dan Kaedah: “Formalin-fixed paraffin-embedded tissue” dari OSCC daripada 
bahagian pipi, gusi, lidah serta juga tisu bukan-kanser oral mukosa dari bahagian yang 
sama digunakan di dalam eksperimen mikroatur gen (DASL, Illumina) untuk 
menentukan pola ekpresinya. Gen-gen yang mengalami perubahan ekpresi yang 
signifikan pada OSCC dikenalpasti dengan Genespring dan disahkan melalui tindak 
balas rantai polimerase kuantitatif dan immunohistokimia. Peranan gen yang spesifik 
dalam memacu OSCC ditentukan dengan mengubahsuai sel OSCC secara genetik untuk 
meluahkan gen secara eksogenus. Keputusan: Kajian ini menunjukkan yang tisu FFPE 
boleh digunakan untuk eksperimen mikroatur gen. Gen yang mengalami perubahan 
pengekpresan yang signifikan di dalam OSCC dikenalpasti dan disahkan menggunakan 
sampel OSCC yang berlainan. “Principal Component Analysis” menunjukkan OSCC 
dari lokasi berbeza di mulut mempunyai pola pengekpresan gen yang berbeza. Ekspresi 
gen yang berubah dalam ketiga-tiga lokasi dan yang hanya berubah di lokasi tertentu 
dikenalpasti. Bertumpu kepada gen FOLR1 yang diperkayai dalam OSCC lidah, luahan 
eksogenus menunjukkan yang ianya menggalakkan ciri-ciri migrasi dan invasi. 
Kesimpulan: Kajian ini menunjukkan yang perkembangan genetik OSCC berbeza 
mengikut lokasi berlainan di mulut. Oleh itu, perhatian perlu diberi kepada faktor ini 
apabila menyamaratakan OSCC dalam pencarian biopenanda diagnosis, prognosis dan 
terapi. Gen tertentu juga boleh memberikan ciri kanser yang berlainan, seterusnya 
menjelaskan perbezaan klinikal yang dilihat pada OSCC dari lokasi yang berbeza.
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